4//SEC Filing
Fratamico Arthur 4
Accession 0001437749-19-024819
CIK 0001029125other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:29 PM ET
Size
7.2 KB
Accession
0001437749-19-024819
Insider Transaction Report
Form 4
Fratamico Arthur
Director
Transactions
- Award
Stock Option (right to buy)
2019-12-19+6,500→ 6,500 totalExercise: $3.70Exp: 2029-12-19→ Common Stock (6,500 underlying) - Award
Stock Option (right to buy)
2019-12-19+26,800→ 26,800 totalExercise: $3.70Exp: 2029-12-19→ Common Stock (26,800 underlying)
Footnotes (2)
- [F1]Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2020.
- [F2]Immediately exercisable as to 50% of the shares and scheduled to vest with respect to 25% of the shares on each of December 19, 2020 and December 19, 2021.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001598129
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:29 PM ET
- Size
- 7.2 KB